News Image

West Reports Third-Quarter 2025 Results

Provided By PR Newswire

Last update: Oct 23, 2025

- Delivered solid growth across Proprietary Products and Contract Manufacturing Segments - 
- Achieved double-digit growth in HVP Components -
- Strengthened executive leadership team, including recently appointed CFO Robert McMahon -
- Increases Full-Year 2025 Revenue and EPS Guidance -

Read more at prnewswire.com

WEST PHARMACEUTICAL SERVICES

NYSE:WST (11/17/2025, 8:04:00 PM)

After market: 262.41 0 (0%)

262.41

+1.05 (+0.4%)



Find more stocks in the Stock Screener

Follow ChartMill for more